Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

NCT02259751 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

DRUG: KUC 7483 CL
DRUG: Placebo

Sponsor

Boehringer Ingelheim